Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Covington
Cerilliant
Queensland Health
Express Scripts
Federal Trade Commission
Colorcon
Julphar

Generated: June 24, 2018

DrugPatentWatch Database Preview

Hq Spclt Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for HQ SPCLT PHARMA, and when can generic versions of HQ SPCLT PHARMA drugs launch?

HQ SPCLT PHARMA has seven approved drugs.

There are four US patents protecting HQ SPCLT PHARMA drugs.

There are forty patent family members on HQ SPCLT PHARMA drugs in twenty-five countries and thirty supplementary protection certificates in eleven countries.

Summary for Hq Spclt Pharma
International Patents:40
US Patents:4
Tradenames:10
Ingredients:6
NDAs:7

Drugs and US Patents for Hq Spclt Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt Pharma MAGNESIUM SULFATE IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 207350-005 Dec 6, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hq Spclt Pharma TAXOL paclitaxel INJECTABLE;INJECTION 020262-001 Dec 29, 1992 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Hq Spclt Pharma ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703-001 Apr 7, 2016 RX Yes Yes 6,310,094 ➤ Try a Free Trial Y ➤ Try a Free Trial
Hq Spclt Pharma ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER esmolol hydrochloride SOLUTION;INTRAVENOUS 205703-001 Apr 7, 2016 RX Yes Yes 8,835,505 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Hq Spclt Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma PLATINOL cisplatin INJECTABLE;INJECTION 018057-001 Approved Prior to Jan 1, 1982 4,177,263 ➤ Try a Free Trial
Hq Spclt Pharma TAXOL paclitaxel INJECTABLE;INJECTION 020262-001 Dec 29, 1992 6,150,398 ➤ Try a Free Trial
Hq Spclt Pharma PLATINOL cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982 4,177,263 ➤ Try a Free Trial
Hq Spclt Pharma PLATINOL cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982 5,562,925 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Hq Spclt Pharma Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00117 Netherlands ➤ Try a Free Trial PRODUCT NAME: DEXMEDETOMIDINE, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH IN FARMACEUTISCH OPZICHT AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZ ONDER DEXMEDETOMIDINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/2/02/033/001 20020830
2014022 Lithuania ➤ Try a Free Trial PRODUCT NAME: PACLITAXELUM; REGISTRATION NO/DATE: EU/1/07/428/001-002 20131220
2012000017 Germany ➤ Try a Free Trial PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
90006-4 Sweden ➤ Try a Free Trial PRODUCT NAME: ACETYLSALICYLSYRA OCH ESOMEPRAZOLMAGNESIUMTRIHYDRAT; NAT. REG. NO/DATE: MTNR 44371 20110930; FIRST REG.: PT 5402359MFL 20110812
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Cerilliant
Accenture
Chinese Patent Office
Healthtrust
Teva
UBS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.